Digital nudge aims to speed up genetic testing for lung cancer
NCT ID NCT05853887
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether an electronic health record reminder (a 'nudge') can prompt doctors to order genetic tests for patients newly diagnosed with advanced non-small cell lung cancer. The goal is to have test results available before starting treatment, so doctors can choose the best therapy. About 260 patients at several Penn Medicine locations will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Electronic health record nudge (a reminder alert for doctors)
What this could lead to
If successful, this could show that simple digital reminders help doctors get genetic test results faster, leading to more personalized treatment for lung cancer patients.
What could go wrong
This is a behavioral study, not a drug trial, so it won't directly treat cancer. The nudge may not change doctor behavior significantly, and results may not apply to other hospitals or cancer types.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Penn Medicine Cherry Hill
Cherry Hill, New Jersey, 08003, United States
-
Penn Medicine Lancaster General Health
Lancaster, Pennsylvania, 17602, United States
-
Penn Medicine Princeton Health
Plainsboro, New Jersey, 08536, United States
-
Penn Medicine Voorhees
Voorhees Township, New Jersey, 08043, United States
-
Penn Medicine Washington Township
Sewell, New Jersey, 08080, United States
-
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, 19104, United States